1537797511007637504

Stem cell research was the focus of #ISSCR2022. Our lead Allo stem cell therapy candidate #omidubicel has the potential to improve health outcomes and #healthdisparities for minority cancer patients based on HEOR study. https://t.co/g0PFHn6aOK
#StemCellTransplant
#HealthEquity https://t.co/eIvLypAmzg

Send us a message